Senaklear
- Product NDC
- 57237-371
- 11-digit product format
- 572370371
- Labeler code
- 57237
- Product ID
- 57237-371_8ed55d41-c5be-44fc-b27d-a2df08763b90
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Sennosides
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Rising Pharma Holdings, Inc.
- Application
- 505G(a)(3)
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2026-09-30
- Substance
- SENNOSIDES
- Active strength
- 8.6 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Senaklear
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| SENNOSIDES | 8.6 mg/1 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 57237-371-01 | 57237037101 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (57237-371-01) | 2026-09-30 | No | No | Current |
| 57237-371-99 | 57237037199 | 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (57237-371-99) | 2026-09-30 | No | No | Current |